Clinical Trial Update: Preoperative Panitumumab and Radiotherapy in Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of preoperative panitumumab in combination with radiotherapy for rectal cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Rectal Cancer | Phase 2 | Status: TERMINATED